Literature DB >> 31740852

Trispecific antibodies offer a third way forward for anticancer immunotherapy.

Alfred L Garfall, Carl H June.   

Abstract

Keywords:  Cancer; Immunology; Medical research

Mesh：

Substances：

Year:  2019        PMID： 31740852     DOI： 10.1038/d41586-019-03495-3

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  9 in total

1.  Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma.

Authors:  Noopur Raje; Jesus Berdeja; Yi Lin; David Siegel; Sundar Jagannath; Deepu Madduri; Michaela Liedtke; Jacalyn Rosenblatt; Marcela V Maus; Ashley Turka; Lyh-Ping Lam; Richard A Morgan; Kevin Friedman; Monica Massaro; Julie Wang; Greg Russotti; Zhihong Yang; Timothy Campbell; Kristen Hege; Fabio Petrocca; M Travis Quigley; Nikhil Munshi; James N Kochenderfer
Journal:  N Engl J Med       Date:  2019-05-02       Impact factor: 91.245

2.  Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.

Authors:  Hagop Kantarjian; Anthony Stein; Nicola Gökbuget; Adele K Fielding; Andre C Schuh; Josep-Maria Ribera; Andrew Wei; Hervé Dombret; Robin Foà; Renato Bassan; Önder Arslan; Miguel A Sanz; Julie Bergeron; Fatih Demirkan; Ewa Lech-Maranda; Alessandro Rambaldi; Xavier Thomas; Heinz-August Horst; Monika Brüggemann; Wolfram Klapper; Brent L Wood; Alex Fleishman; Dirk Nagorsen; Christopher Holland; Zachary Zimmerman; Max S Topp
Journal:  N Engl J Med       Date:  2017-03-02       Impact factor: 91.245

3.  T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.

Authors:  Jennifer N Brudno; Irina Maric; Steven D Hartman; Jeremy J Rose; Michael Wang; Norris Lam; Maryalice Stetler-Stevenson; Dalia Salem; Constance Yuan; Steven Pavletic; Jennifer A Kanakry; Syed Abbas Ali; Lekha Mikkilineni; Steven A Feldman; David F Stroncek; Brenna G Hansen; Judith Lawrence; Rashmika Patel; Frances Hakim; Ronald E Gress; James N Kochenderfer
Journal:  J Clin Oncol       Date:  2018-05-29       Impact factor: 44.544

Review 4.  Chimeric Antigen Receptor Therapy.

Authors:  Carl H June; Michel Sadelain
Journal:  N Engl J Med       Date:  2018-07-05       Impact factor: 91.245

5.  Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia.

Authors:  Nicola Gökbuget; Hervé Dombret; Massimiliano Bonifacio; Albrecht Reichle; Carlos Graux; Christoph Faul; Helmut Diedrich; Max S Topp; Monika Brüggemann; Heinz-August Horst; Violaine Havelange; Julia Stieglmaier; Hendrik Wessels; Vincent Haddad; Jonathan E Benjamin; Gerhard Zugmaier; Dirk Nagorsen; Ralf C Bargou
Journal:  Blood       Date:  2018-01-22       Impact factor: 22.113

6.  Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.

Authors:  Ling Xu; Amarendra Pegu; Ercole Rao; Nicole Doria-Rose; Jochen Beninga; Krisha McKee; Dana M Lord; Ronnie R Wei; Gejing Deng; Mark Louder; Stephen D Schmidt; Zachary Mankoff; Lan Wu; Mangaiarkarasi Asokan; Christian Beil; Christian Lange; Wulf Dirk Leuschner; Jochen Kruip; Rebecca Sendak; Young Do Kwon; Tongqing Zhou; Xuejun Chen; Robert T Bailer; Keyun Wang; Misook Choe; Lawrence J Tartaglia; Dan H Barouch; Sijy O'Dell; John-Paul Todd; Dennis R Burton; Mario Roederer; Mark Connors; Richard A Koup; Peter D Kwong; Zhi-Yong Yang; John R Mascola; Gary J Nabel
Journal:  Science       Date:  2017-09-20       Impact factor: 47.728

7.  Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma.

Authors:  Henk M Lokhorst; Torben Plesner; Jacob P Laubach; Hareth Nahi; Peter Gimsing; Markus Hansson; Monique C Minnema; Ulrik Lassen; Jakub Krejcik; Antonio Palumbo; Niels W C J van de Donk; Tahamtan Ahmadi; Imran Khan; Clarissa M Uhlar; Jianping Wang; A Kate Sasser; Nedjad Losic; Steen Lisby; Linda Basse; Nikolai Brun; Paul G Richardson
Journal:  N Engl J Med       Date:  2015-08-26       Impact factor: 91.245

8.  Disability Related to Chronic Graft-versus-Host Disease.

Authors:  Betty K Hamilton; Barry E Storer; William A Wood; Joseph A Pidala; Corey S Cutler; Paul J Martin; George Chen; Mary E Flowers; Stephanie J Lee
Journal:  Biol Blood Marrow Transplant       Date:  2019-10-24       Impact factor: 5.742

9.  A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients.

Authors:  Chaoyang Sun; Ensong Guo; Bo Zhou; Wanying Shan; Jia Huang; Danhui Weng; Peng Wu; Changyu Wang; Shixuan Wang; Wei Zhang; Qinglei Gao; Xiaoyan Xu; Beibei Wang; Junbo Hu; Ding Ma; Gang Chen
Journal:  BMC Cancer       Date:  2019-11-08       Impact factor: 4.430
  9 in total
  6 in total

Review 1.  The cure of leukemia through the optimist's prism.

Authors:  Hagop M Kantarjian; Nitin Jain; Guillermo Garcia-Manero; Mary Alma Welch; Farhad Ravandi; William G Wierda; Elias J Jabbour
Journal:  Cancer       Date:  2021-10-06       Impact factor: 6.860

Review 2.  Biological approaches for hypertrophic scars.

Authors:  Zhong Lingzhi; Li Meirong; Fu Xiaobing
Journal:  Int Wound J       Date:  2019-12-20       Impact factor: 3.315

3.  Single- and double-hit events in genes encoding immune targets before and after T cell-engaging antibody therapy in MM.

Authors:  Marietta S Truger; Johannes Duell; Xiang Zhou; Larissa Heimeshoff; Anna Ruckdeschel; Mara John; Angela Riedel; Sebastian Hüper; Jessica Peter; Wencke Walter; Larissa Haertle; Manja Meggendorfer; Max S Topp; Andreas Rosenwald; Matteo Claudio Da Via; Niccolo Bolli; Niels Weinhold; Hermann Einsele; Claudia Haferlach; K Martin Kortüm; Leo Rasche
Journal:  Blood Adv       Date:  2021-10-12

4.  Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells.

Authors:  Longchao Liu; Jiahui Chen; Joonbeom Bae; Huiyu Li; Zhichen Sun; Casey Moore; Eric Hsu; Chuanhui Han; Jian Qiao; Yang-Xin Fu
Journal:  Nat Biomed Eng       Date:  2021-11-01       Impact factor: 29.234

Review 5.  Targeting macrophages in hematological malignancies: recent advances and future directions.

Authors:  Wei Li; Fang Wang; Rongqun Guo; Zhilei Bian; Yongping Song
Journal:  J Hematol Oncol       Date:  2022-08-17       Impact factor: 23.168

Review 6.  Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment.

Authors:  Franziska Füchsl; Angela M Krackhardt
Journal:  Cancers (Basel)       Date:  2022-08-29       Impact factor: 6.575
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.